These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19397797)

  • 1. Anti-malarial prescriptions in three health care facilities after the emergence of chloroquine resistance in Niakhar, Senegal (1992-2004).
    Munier A; Diallo A; Cot M; Ndiaye O; Arduin P; Chippaux JP
    Malar J; 2009 Apr; 8():83. PubMed ID: 19397797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
    Tekete M; Djimde AA; Beavogui AH; Maiga H; Sagara I; Fofana B; Ouologuem D; Dama S; Kone A; Dembele D; Wele M; Dicko A; Doumbo OK
    Malar J; 2009 Feb; 8():34. PubMed ID: 19245687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
    Ogungbamigbe TO; Ojurongbe O; Ogunro PS; Okanlawon BM; Kolawole SO
    Mem Inst Oswaldo Cruz; 2008 Feb; 103(1):79-84. PubMed ID: 18368238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
    Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
    Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria.
    Müller O; van Hensbroek MB; Jaffar S; Drakeley C; Okorie C; Joof D; Pinder M; Greenwood B
    Trop Med Int Health; 1996 Feb; 1(1):124-32. PubMed ID: 8673817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
    Mubyazi GM; Gonzalez-Block MA
    Malar J; 2005 Oct; 4():51. PubMed ID: 16242017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
    Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
    Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.
    Mohapatra PK; Prakash A; Taison K; Negmu K; Gohain AC; Namchoom NS; Wange D; Bhattacharyya DR; Goswami BK; Borgohain BK; Mahanta J
    Trop Med Int Health; 2005 May; 10(5):478-83. PubMed ID: 15860095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial prescribing practices: a challenge to malaria control in Ghana.
    Abuaku BK; Koram KA; Binka FN
    Med Princ Pract; 2005; 14(5):332-7. PubMed ID: 16103699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of chloroquine and sulphadoxine-pyrimethamine either alone or in combination before introduction of ACT as first-line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India.
    Mullick S; Das S; Guha SK; Bera DK; Sengupta S; Roy D; Saha P; Biswas A; Das M; Ray K; Kundu PK; Maji AK
    Trop Med Int Health; 2011 Aug; 16(8):929-35. PubMed ID: 21564429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in malaria case management following changes in the treatment policy to artemisinin combination therapy at the Mbakong Health Centre, Cameroon 2006-2012: a retrospective study.
    Ndong IC; Reenen Mv; Boakye DA; Mbacham WF; Grobler AF
    Acta Trop; 2015 Oct; 150():100-6. PubMed ID: 26095044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance.
    Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Situakibanza HNT; Likwela JL; De Mol P; Okitolonda EW; Speybroeck N; Mvumbi GL; Hayette MP
    Malar J; 2020 Mar; 19(1):121. PubMed ID: 32197607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children.
    Talisuna AO; Nalunkuma-Kazibwe A; Bakyaita N; Langi P; Mutabingwa TK; Watkins WW; Van Marck E; D'Alessandro U; Egwang TG
    Trop Med Int Health; 2004 Feb; 9(2):222-9. PubMed ID: 15040559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of an impact of resistance to chloroquine on consultations for malaria in Niakhar, Senegal (1992-2004).
    Munier A; Diallo A; Chippaux JP
    Trans R Soc Trop Med Hyg; 2009 Dec; 103(12):1288-90. PubMed ID: 19394663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine.
    Checchi F; Roddy P; Kamara S; Williams A; Morineau G; Wurie AR; Hora B; Lamotte Nd; Baerwaldt T; Heinzelmann A; Danks A; Pinoges L; Oloo A; Durand R; Ranford-Cartwright L; Smet M;
    Trop Med Int Health; 2005 Feb; 10(2):146-53. PubMed ID: 15679557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs.
    Sowunmi A; Fateye BA
    Trop Med Int Health; 2003 Sep; 8(9):783-92. PubMed ID: 12950664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential contribution of prescription practices to the emergence and spread of chloroquine resistance in south-west Nigeria: caution in the use of artemisinin combination therapy.
    Gbotosho GO; Happi CT; Ganiyu A; Ogundahunsi OA; Sowunmi A; Oduola AM
    Malar J; 2009 Dec; 8():313. PubMed ID: 20042098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.